Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

GLOBAL MARKETS-Stocks rally on vaccine hopes, oil gains crude drawdown

Published 16/07/2020, 01:38 am
© Reuters.
EUR/USD
-
USD/JPY
-
USD/SEK
-
US500
-
DJI
-
JP225
-
HK50
-
GS
-
JPM
-
WFC
-
LCO
-
CL
-
IXIC
-
FTEU3
-
CSI300
-
MRNA
-

* COVID vaccine hopes drives risk-on sentiment

* Economic, crude oil data help growth outlook

* Simmering U.S.-Sino tensions remain a concern

By Herbert Lash and Marc Jones

NEW YORK/LONDON, July 15 (Reuters) - World shares strode to four-month highs on Wednesday as hopes for a coronavirus vaccine offset rising U.S.-China tensions and helped lift the euro and oil prices too.

Asian markets were choppy after more barbs between Beijing and Washington over Hong Kong but gains of around 2% in European bourses and a solid advance on Wall Street set aside concerns about the still growing number of COVID cases.

An experimental vaccine produced by Moderna Inc MRNA.O drew safe immune responses in all 45 healthy volunteers, an early stage trial showed on Tuesday. There were reports on Wednesday that a separate University of Oxford trial was also looking good. Treasury yields rose and the yield curve steepened, indicating a wider spread between long- and short-term interest rates, as vaccine hopes boosted risk appetite and surprising data released on Wednesday added to the optimism.

U.S. industrial production, manufacturing output and plant capacity rose more than expected in June and there was a bigger- than-expected draw in U.S. crude and refined products last week. market is trading fairly 'risk on' on vaccine hopes," said Gennadiy Goldberg, an interest rate strategist at TD Securities in New York. "It's largely COVID news driving the price action recently."

Europe's broad FTSEurofirst 300 index .FTEU3 advanced 1.78%, while on Wall Street, the Dow Jones Industrial Average .DJI rose 0.74%, the S&P 500 .SPX gained 0.66% and the Nasdaq Composite .IXIC added 0.13%.

Moderna surged 10.2% to a record high after a small-scale study showed its experimental vaccine produced high levels of virus-killing antibodies, bolstering hopes it could prove effective in later stages of testing. of progress this week towards a deal on the European Union's 750 billion-euro COVID recovery fund helped sentiment in Europe. The euro traded above $1.1430 EUR= for the first time since March, and Italy and Spain's bond market borrowing costs came down again. .EU /FRX GVD/EUR

The euro EUR= was last up 0.18% at $1.1416.

Chinese shares fell 1.3% .CSI300 and Hong Kong .HSI ended flat, after U.S. President Donald Trump ordered an end to Hong Kong's special status under U.S. law to punish China for its "oppressive actions" against the former British colony.

That prompted a retaliatory warning from China's foreign ministry that "Hong Kong affairs are purely China's internal affairs and no foreign country has the right to interfere". Nikkei .N225 and Australia's benchmark index remained upbeat, finishing up 1.6% and 1.9%, respectively.

Investment bank Goldman Sachs (NYSE:GS) GS.N was also pointing higher after reporting higher quarterly profits following the COVID crisis trading boom. JPMorgan (NYSE:JPM), Citi and Wells Fargo (NYSE:WFC) had reported huge Q2 profit drops on Tuesday and set aside a collective $28 billion for loan losses. ALERT

The dollar was on the defensive, particularly against risk-sensitive currencies, following the news of progress in vaccine development. /FRX

Sweden's crown SEK= vaulted to its highest versus the greenback since February 2019 and the risk-sensitive Australian dollar popped to a one-month high at $0.70 AUD=D4 .

The yen JPY= was down 0.29% at $106.9200.

The Bank of Japan kept its monetary policy steady, as expected, on Wednesday though it warned that uncertainty over the economic outlook was "extremely high" due to various risks, including rising coronavirus infections in Tokyo, which was put on "red alert" on Wednesday. rose on the sharp drop in U.S. inventories, but further gains were limited as the Organization of the Petroleum Exporting Countries and allies are set to ease supply curbs from August as the global economy recovers from the pandemic.

Brent crude LCOc1 rose 1.1% at $43.37 a barrel. U.S. crude CLc1 advanced 1.04% at $40.71 a barrel.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global assets

http://tmsnrt.rs/2jvdmXl Global currencies vs. dollar

http://tmsnrt.rs/2egbfVh Emerging markets

http://tmsnrt.rs/2ihRugV MSCI All Country Wolrd Index Market Cap

http://tmsnrt.rs/2EmTD6j Bulls in the China shop

https://tmsnrt.rs/2WlCDoC

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.